Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Low-coverage sequencing cost-effectively detects known and novel variation in underrepresented populations

Domain:

healthcare

Record type:

dataset
Creator:
AliEliSinAnn
Publisher:
ope
Host:
Abstract Background Genetic studies of biomedical phenotypes in underrepresented populations identify disproportionate numbers of novel associations. However, current genomics infrastructure--including most genotyping arrays and sequenced reference panels--best serves populations of European descent. A critical step for facilitating genetic studies in underrepresented populations is to ensure that genetic technologies accurately capture variation in all populations. Here, we quantify the accuracy of low-coverage sequencing in diverse African populations. Results We sequenced the whole genomes of 91 individuals to high-coverage (≥20X) from the Neuropsychiatric Genetics of African Population-Psychosis (NeuroGAP-Psychosis) study, in which participants were recruited from Ethiopia, Kenya, South Africa, and Uganda. We empirically tested two data generation strategies, GWAS arrays versus low-coverage sequencing, by calculating the concordance of imputed variants from these technologies with those from deep whole genome sequencing data. We show that low-coverage sequencing at a depth of ≥4X captures variants of all frequencies more accurately than all commonly used GWAS arrays investigated and at a comparable cost. Lower depths of sequencing (0.5-1X) performed comparable to commonly used low-density GWAS arrays. Low-coverage sequencing is also sensitive to novel variation, with 4X sequencing detecting 45% of singletons and 95% of common variants identified in high-coverage African whole genomes. Conclusion These results indicate that low-coverage sequencing approaches surmount the problems induced by the ascertainment of common genotyping arrays, including those that capture variation most common in Europeans and Africans. Low-coverage sequencing effectively identifies novel variation (particularly in underrepresented populations), and presents opportunities to enhance variant discovery at a similar cost to traditional approaches.

Visit

doi.org

Similar

The impact of low-coverage whole-genome sequencing on advancing genetic epidemiology studies in global populationsGenotype calls from whole genome sequencing: Turkana low coverage samplesChronic diseases are not being managed effectively in either high-risk or low-risk populations in South AfricaApple cultivars used for low coverage re-sequencing and subsequent single nucleotide polymorphism detection.Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA SequencingA Novel Low-cost Bubble CPAP device with Pressure Monitoring and Controlling System for Low Resource Settings

The impact of low-coverage whole-genome sequencing on advancing genetic epidemiology studies in global populations

Genetic epidemiology connects genomics with population health, offering insights into disease suscep

Genotype calls from whole genome sequencing: Turkana low coverage samples

This project contains datasets related to: Adaptations to water stress and pastoralism in the Turka

Chronic diseases are not being managed effectively in either high-risk or low-risk populations in South Africa

Apple cultivars used for low coverage re-sequencing and subsequent single nucleotide polymorphism detection.

An approximate genome coverage was estimated for each accession using a genome size of 750 Mb. Th

Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing

PURPOSE: Most cases of pediatric acute leukemia occur in low- and middle-income countries, where

A Novel Low-cost Bubble CPAP device with Pressure Monitoring and Controlling System for Low Resource Settings

Purpose: Africa contributed to one-third of the world’s neonatal mortality burden. In the sub-Sahara